Atlas Trials

Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT04956042 · TERMINATED

Trial details

NCT number
NCT04956042
Sponsor
CicloMed LLC
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Refractory Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia
Start date
2021-08-27
Primary completion
2023-12-31
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.